Table 4.
Variables | Low variability (n = 81) | High variability (n = 81) |
---|---|---|
Age (years) | 50 ± 14 | 55 ± 16* |
Male, n (%) | 52 (64.2) | 54 (66.4) |
BMI (kg/m2) | 27.3 ± 5.7 | 28.2 ± 6.9 |
Current smoking, n (%) | 38 (46.9) | 40 (49.4) |
Clinic-SBP (mm Hg) | 142 ± 17 | 143 ± 18 |
Clinic-DBP (mm Hg) | 85 ± 10 | 86 ± 10 |
Clinic-HR (bpm) | 78 ± 9 | 79 ± 13 |
FPG (mmol/L) | 5.5 ± 0.5 | 5.6 ± 0.4 |
TC (mmol/L) | 5.1 ± 0.5 | 5.2 ± 0.4 |
TG (mmol/L) | 1.8 ± 0.7 | 1.9 ± 0.8 |
HDL-C (mmol/L) | 1.1 ± 0.5 | 1.1 ± 0.4 |
LDL-C (mmol/L) | 3.4 ± 0.5 | 3.3 ± 0.6 |
Cr (umol/L) | 70.6 ± 13.5 | 72.2 ± 13.9 |
Hs-CRP (mg/dL) | 8.8 ± 3.0 | 10.2 ± 4.6 |
24 h–SBP (mm Hg) | 132 ± 13 | 137 ± 15* |
24 h–DBP (mm Hg) | 78 ± 10 | 79 ± 12 |
24-HR (beat per minute) | 72 ± 12 | 74 ± 13 |
Weighted 24 h–SD of SBP (mm Hg) | 12.6 ± 3.7 | 16.0 ± 4.9* |
Weighted 24 h–SD of DBP (mm Hg) | 7.4 ± 1.5 | 8.0 ± 2.2 |
Daytime-SBP (mm Hg) | 137 ± 11 | 143 ± 18* |
Daytime-DBP (mm Hg) | 81 ± 11 | 85 ± 14 |
Daytime-HR (beat per minute) | 77 ± 12 | 80 ± 15 |
Weighted daytime-SD of SBP (mm Hg) | 14.7 ± 4.0 | 17.9 ± 5.2* |
Weighted daytime-SD of DBP (mm Hg) | 8.1 ± 1.6 | 8.5 ± 2.3 |
Nighttime-SBP (mm Hg) | 128 ± 11 | 133 ± 14* |
Nighttime-DBP (mm Hg) | 73 ± 6 | 77 ± 8 |
Nighttime-HR (beat per minute) | 64 ± 7 | 68 ± 9 |
Weighted nighttime-SD of SBP (mm Hg) | 10.8 ± 1.5 | 13.9 ± 2.1* |
Weighted nighttime-SD of DBP (mm Hg) | 6.5 ± 1.0 | 7.2 ± 1.3 |
AHI (events/h) | 9.9 ± 4.5 | 13.8 ± 7.6* |
CVD, n (%) | 31 (38.3) | 35 (43.2)* |
Anti-platelet agent, n (%) | 34 (42.0) | 34 (42.0) |
Statins, n (%) | 29 (35.8) | 30 (37.0) |
ACEI/ARB, n (%) | 58 (71.6) | 61 (75.3)* |
CCB, n (%) | 17 (21.0) | 16 (19.8) |
Diuretic, n (%) | 26 (32.1) | 26 (32.1) |
Beta-blocker, n (%) | 18 (22.2) | 37 (23.5) |
Alpha-blocker, n (%) | 5 (6.2) | 5 (6.2) |
Anti-HTN medications number | 2.3 ± 0.7 | 2.6 ± 0.9 |
Abbreviation is the same as the Table 1; * P < 0.05 vs low variability group